MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy

MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy

Microtubule affinity-regulating kinase (MARK4) plays a key role in Alzheimer’s disease (AD) development as its overexpression is directly linked to increased tau phosphorylation. MARK4 is a potential drug target of AD and is thus its structural features are employed in the development of new therape...

Full description

Bibliographic Details
Main Authors:	Anas Shamsi, Saleha Anwar, Taj Mohammad, Mohamed F. Alajmi, Afzal Hussain, Md. Tabish Rehman, Gulam Mustafa Hasan, Asimul Islam, Md. Imtaiyaz Hassan
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	Biomolecules
Subjects:	acetylcholinesterase inhibitors drug design and discovery kinase inhibitors molecular modeling and docking isothermal titration calorimetry Alzheimer’s disease
Online Access:	https://www.mdpi.com/2218-273X/10/5/789

Similar Items

Unraveling Binding Mechanism of Alzheimer’s Drug Rivastigmine Tartrate with Human Transferrin: Molecular Docking and Multi-Spectroscopic Approach towards Neurodegenerative Diseases
by: Anas Shamsi, et al.
Published: (2019-09-01)

Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study
by: Terrone L. Rosenberry, et al.
Published: (2017-11-01)

Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors
by: Keith D. Green, et al.
Published: (2018-12-01)

Evaluation of the Adverse Effects of Chronic Exposure to Donepezil (An Acetylcholinesterase Inhibitor) in Adult Zebrafish by Behavioral and Biochemical Assessments
by: Gilbert Audira, et al.
Published: (2020-09-01)

Quetiapine and novel PDE10A inhibitors potentiate the anti-BuChE activity of donepezil
by: Joanna Sikora, et al.
Published: (2020-01-01)

The protective role of tacrine and donepezil in the retina of acetylcholinesterase knockout mice
by: Yun-Min Yi, et al.
Published: (2015-10-01)

Synthesis of New Indole Derivatives Structurally Related to Donepezil and Their Biological Evaluation as Acetylcholinesterase Inhibitors
by: Samar I. Faggal, et al.
Published: (2012-04-01)

Study of jack bean urease interaction with luteolin by the extended solvation model and docking simulation
by: Maryam Mazinani, et al.
Published: (2020-12-01)

Postoperative Administration of the Acetylcholinesterase Inhibitor, Donepezil, Interferes with Bone Healing and Implant Osseointegration in A Rat Model
by: Faez Saleh Al-Hamed, et al.
Published: (2020-09-01)

Cognitive impairment and electroconvulsive therapy in geriatric depression, what could be the role of rivastigmine? A case series
by: Audrey Monica van Schaik, et al.
Published: (2015-09-01)

Multispectroscopic and Molecular Docking Insight into Elucidating the Interaction of Irisin with Rivastigmine Tartrate: A Combinational Therapy Approach to Fight Alzheimer’s Disease
by: Rashid Waseem, et al.
Published: (2021-03-01)

Rationalizing the Role of Monosodium Glutamate in the Protein Aggregation Through Biophysical Approaches: Potential Impact on Neurodegeneration
by: Ishfaq Ahmad Ahanger, et al.
Published: (2021-03-01)

Synthesis and evaluation of novel coumarin-donepezil derivatives as dual acting monoamine oxidase B and cholinesterase in Alzheimer's disease
by: Foka, Germaine Boulenoue
Published: (2017)

Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
by: Zhang N, et al.
Published: (2018-10-01)

Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis
by: Łucja Justyna Walczak-Nowicka, et al.
Published: (2021-08-01)

Structural Refolding and Thermal Stability of Myoglobin in the Presence of Mixture of Crowders: Importance of Various Interactions for Protein Stabilization in Crowded Conditions
by: Zahoor Ahmad Parray, et al.
Published: (2021-05-01)

Tertiary amine derivatives of chlorochalcone as acetylcholinesterase (AChE) and buthylcholinesterase (BuChE) inhibitors: the influence of chlorine, alkyl amine side chain and α,β-unsaturated ketone group
by: Xiao-hui Gao, et al.
Published: (2017-01-01)

Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy
by: Campbell NL, et al.
Published: (2015-01-01)

Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial
by: Wade AG, et al.
Published: (2014-06-01)

Alzheimer disease and acetylcholinesterase inhibitors
by: Zahia Kabouche
Published: (2016-12-01)

A 24-Week, Randomized, Controlled Study to Evaluate the Tolerability, Safety and Efficacy of 2 Different Titration Schemes of the Rivastigmine Patch in Japanese Patients with Mild to Moderate Alzheimer's Disease
by: Yu Nakamura, et al.
Published: (2015-09-01)

Structural Isomerism and Enhanced Lipophilicity of Pyrithione Ligands of Organoruthenium(II) Complexes Increase Inhibition on AChE and BuChE
by: Jerneja Kladnik, et al.
Published: (2020-08-01)

Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific Region
by: Marwan Sabbagh, et al.
Published: (2016-09-01)

Community Pharmacists’ Knowledge Regarding Donepezil Averse Effects and Self-Care Recommendations for Insomnia for Persons with AD
by: Marketa Marvanova, et al.
Published: (2017-07-01)

A simple and direct HPLC-DAD method for the simultaneous determination of galantamine, donepezil and rivastigmine in cerebrospinal fluid, blood serum and urine
by: Maria Petrocheilou, et al.
Published: (2017-06-01)

Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer’s Disease: Are Irreversible Inhibitors the Future?
by: Donald E. Moss
Published: (2020-05-01)

Peptide–polymer ligands for a tandem WW-domain, an adaptive multivalent protein–protein interaction: lessons on the thermodynamic fitness of flexible ligands
by: Katharina Koschek, et al.
Published: (2015-05-01)

Dissecting the Structure–Activity Relationship of Galectin–Ligand Interactions
by: Yi-Chen Chan, et al.
Published: (2018-01-01)

Crystal structure correlations with the intrinsic thermodynamics of human carbonic anhydrase inhibitor binding
by: Alexey Smirnov, et al.
Published: (2018-02-01)

Interactions Under Crowding Milieu: Chemical-Induced Denaturation of Myoglobin is Determined by the Extent of Heme Dissociation on Interaction with Crowders
by: Khalida Nasreen, et al.
Published: (2020-03-01)

Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy
by: Preeti Gupta, et al.
Published: (2019-10-01)

Synthesis and molecular docking studies of some 4-phthalimidobenzenesulfonamide derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors
by: Zeynep Soyer, et al.
Published: (2017-01-01)

Oximes: Inhibitors of Human Recombinant Acetylcholinesterase. A Structure-Activity Relationship (SAR) Study
by: Kamil Kuca, et al.
Published: (2013-08-01)

Active anti-acetylcholinesterase component of secondary metabolites produced by the endophytic fungi of Huperzia serrata
by: Zhejian Wang, et al.
Published: (2015-11-01)

Isothermal Microcalorimetry to Investigate Non Specific Interactions in Biophysical Chemistry
by: Vincent Ball, et al.
Published: (2009-07-01)

Isoperibolic Titration Calorimetry as a Tool for the Prediction of Thermodynamic Properties of Cyclodextrins
by: Liliana Giraldo, et al.
Published: (2008-10-01)

The Evaluation of Benefit of Newly Prepared Reversible Inhibitors of Acetylcholinesterase and Commonly Used Pyridostigmine as Pharmacological Pretreatment of Soman-Poisoned Mice
by: Jiří Kassa, et al.
Published: (2017-06-01)

Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy
by: Preeti Gupta, et al.
Published: (2021-04-01)

IMPLICATIONS AND CLINICAL MANAGEMENT OF MYASTHENIA GRAVIS DURING PREGNANCY
by: Andreea Elena DUMITRU, et al.
Published: (2020-06-01)

STRUCTURE-ACTIVITY RELATIONSHIP STUDY OF DITERPENES FOR TREATMENT OF ALZHEIMER'S DISEASE
by: Gabriel F. dos Santos, et al.